Aconitase Causes Iron Toxicity in Drosophila pink1 Mutants
暂无分享,去创建一个
P. Verstreken | G. Esposito | Jef Swerts | Sven Vilain | O. Schaap | M. Vos | S. Van Meensel | Jorge De Sousa Valadas
[1] Houeto Jean-Luc. [Parkinson's disease]. , 2022, La Revue du praticien.
[2] Janaka N. Edirisinghe,et al. Vitamin K2 Is a Mitochondrial Electron Carrier That Rescues Pink1 Deficiency , 2012, Science.
[3] H. Koh,et al. PINK1 as a molecular checkpoint in the maintenance of mitochondrial function and integrity , 2012, Molecules and cells.
[4] H. Kim,et al. Silent Information Regulator 2 (Sir2) and Forkhead Box O (FOXO) Complement Mitochondrial Dysfunction and Dopaminergic Neuron Loss in Drosophila PTEN-induced Kinase 1 (PINK1) Null Mutant* , 2012, The Journal of Biological Chemistry.
[5] R. Youle,et al. PINK1- and Parkin-mediated mitophagy at a glance , 2012, Journal of Cell Science.
[6] P. Verstreken,et al. The Yeast Complex I Equivalent NADH Dehydrogenase Rescues pink1 Mutants , 2012, PLoS genetics.
[7] B. Lu,et al. Mitochondrial dynamics and mitophagy in Parkinson's disease: disordered cellular power plant becomes a big deal in a major movement disorder , 2011, Current Opinion in Neurobiology.
[8] Su Guo,et al. The PINK1/Parkin pathway regulates mitochondrial dynamics and function in mammalian hippocampal and dopaminergic neurons. , 2011, Human molecular genetics.
[9] Kindiya D. Geghman,et al. Pink1 regulates the oxidative phosphorylation machinery via mitochondrial fission , 2011, Proceedings of the National Academy of Sciences.
[10] O. Shirihai,et al. The interplay between mitochondrial dynamics and mitophagy. , 2011, Antioxidants & redox signaling.
[11] H. Hsieh-Li,et al. Mitochondrial Dysfunction and Oxidative Stress Contribute to the Pathogenesis of Spinocerebellar Ataxia Type 12 (SCA12)* , 2011, The Journal of Biological Chemistry.
[12] P. Verstreken,et al. Loss of Skywalker Reveals Synaptic Endosomes as Sorting Stations for Synaptic Vesicle Proteins , 2011, Cell.
[13] S. Weber,et al. The PINK1/Parkin-mediated mitophagy is compromised by PD-associated mutations , 2010, Autophagy.
[14] Ted M. Dawson,et al. Genetic Animal Models of Parkinson's Disease , 2010, Neuron.
[15] J. T. Greenamyre,et al. Mitochondrial iron metabolism and its role in neurodegeneration. , 2010, Journal of Alzheimer's disease : JAD.
[16] D. Sgroi,et al. Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis , 2010, Proceedings of the National Academy of Sciences.
[17] Fabienne C. Fiesel,et al. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1 , 2010, Nature Cell Biology.
[18] Atsushi Tanaka,et al. PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin , 2010, PLoS biology.
[19] Rachel Jones. The Roles of PINK1 and Parkin in Parkinson's Disease , 2010, PLoS biology.
[20] J. Schaack,et al. Oxidative Inactivation of Mitochondrial Aconitase Results in Iron and H2O2-Mediated Neurotoxicity in Rat Primary Mesencephalic Cultures , 2009, PloS one.
[21] R. Habets,et al. Tweek, an Evolutionarily Conserved Protein, Is Required for Synaptic Vesicle Recycling , 2009, Neuron.
[22] J. Connor,et al. Iron, the substantia nigra and related neurological disorders. , 2009, Biochimica et biophysica acta.
[23] Victor Tapias,et al. A highly reproducible rotenone model of Parkinson's disease , 2009, Neurobiology of Disease.
[24] P. Verstreken,et al. Parkinson's disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function , 2009, EMBO molecular medicine.
[25] Hansong Deng,et al. The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila , 2008, Proceedings of the National Academy of Sciences.
[26] Jie Shen,et al. Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress , 2008, Proceedings of the National Academy of Sciences.
[27] M. Beal,et al. Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery , 2008, Proceedings of the National Academy of Sciences.
[28] Angela C. Poole,et al. The PINK1/Parkin pathway regulates mitochondrial morphology , 2008, Proceedings of the National Academy of Sciences.
[29] B. Dickson,et al. A genome-wide transgenic RNAi library for conditional gene inactivation in Drosophila , 2007, Nature.
[30] R. Maeda,et al. An optimized transgenesis system for Drosophila using germ-line-specific φC31 integrases , 2007, Proceedings of the National Academy of Sciences.
[31] Christina Chan,et al. Hydrogen peroxide and hydroxyl radicals mediate palmitate-induced cytotoxicity to hepatoma cells: Relation to mitochondrial permeability transition , 2007, Free radical research.
[32] Hugo J. Bellen,et al. P[acman]: A BAC Transgenic Platform for Targeted Insertion of Large DNA Fragments in D. melanogaster , 2006, Science.
[33] M. Beal,et al. Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[34] Sunhong Kim,et al. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin , 2006, Nature.
[35] Changan Jiang,et al. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin , 2006, Nature.
[36] B. Dunkov,et al. Characterization of mitochondrial ferritin in Drosophila. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[37] P. Verstreken,et al. Synaptic Mitochondria Are Critical for Mobilization of Reserve Pool Vesicles at Drosophila Neuromuscular Junctions , 2005, Neuron.
[38] Jin Man Kim,et al. Parkin negatively regulates JNK pathway in the dopaminergic neurons of Drosophila. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[39] Sunil Q. Mehta,et al. The v-ATPase V0 Subunit a1 Is Required for a Late Step in Synaptic Vesicle Exocytosis in Drosophila , 2005, Cell.
[40] Robin Shattock,et al. In Vitro and In Vivo: The Story of Nonoxynol 9 , 2005, Journal of acquired immune deficiency syndromes.
[41] F. Zoccarato,et al. Dopamine-derived dopaminochrome promotes H(2)O(2) release at mitochondrial complex I: stimulation by rotenone, control by Ca(2+), and relevance to Parkinson disease. , 2005, The Journal of biological chemistry.
[42] S. Birman,et al. Chronic Exposure to Rotenone Models Sporadic Parkinson's Disease in Drosophila melanogaster , 2004, The Journal of Neuroscience.
[43] G. Mardon,et al. Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress , 2004, Development.
[44] T. Dawson,et al. Molecular Pathways of Neurodegeneration in Parkinson's Disease , 2003, Science.
[45] W. Dauer,et al. Parkinson's Disease Mechanisms and Models , 2003, Neuron.
[46] F. Petrat,et al. Selective determination of mitochondrial chelatable iron in viable cells with a new fluorescent sensor. , 2002, The Biochemical journal.
[47] Todd B. Sherer,et al. Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.
[48] B. Kalyanaraman,et al. Mitochondrial Aconitase Is a Source of Hydroxyl Radical , 2000, The Journal of Biological Chemistry.
[49] A. Cederbaum,et al. Mitochondrial permeability transition induced by 1-hydroxyethyl radical. , 2000, Free radical biology & medicine.
[50] S. Berman,et al. Dopamine Oxidation Alters Mitochondrial Respiration and Induces Permeability Transition in Brain Mitochondria , 1999, Journal of neurochemistry.
[51] I. Fridovich,et al. Critical evaluation of the use of hydroethidine as a measure of superoxide anion radical. , 1998, Free radical biology & medicine.
[52] A. Vercesi,et al. The Role of Reactive Oxygen Species in Mitochondrial Permeability Transition , 1997, Bioscience reports.
[53] J. Turrens. Superoxide Production by the Mitochondrial Respiratory Chain , 1997, Bioscience reports.
[54] B. Robinson,et al. Mitochondrial complex I deficiency leads to increased production of superoxide radicals and induction of superoxide dismutase. , 1996, The Journal of clinical investigation.
[55] R. Klausner,et al. The bifunctional iron-responsive element binding protein/cytosolic aconitase: the role of active-site residues in ligand binding and regulation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[56] G. Dryhurst,et al. Effects of L-cysteine on the oxidation chemistry of dopamine: new reaction pathways of potential relevance to idiopathic Parkinson's disease. , 1994, Journal of medicinal chemistry.
[57] H. Beinert,et al. Aconitase, a two‐faced protein: enzyme and iron regulatory factor 1 2 , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[58] C. Stout,et al. Crystal structures of aconitase with isocitrate and nitroisocitrate bound. , 1993, Biochemistry.
[59] D. Flint,et al. The inactivation of Fe-S cluster containing hydro-lyases by superoxide. , 1993, The Journal of biological chemistry.
[60] P. R. Gardner,et al. Superoxide sensitivity of the Escherichia coli aconitase. , 1991, The Journal of biological chemistry.
[61] P Riederer,et al. Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains , 1991, Journal of neurochemistry.
[62] P. R. Gardner,et al. Superoxide sensitivity of the Escherichia coli 6-phosphogluconate dehydratase. , 1991, The Journal of biological chemistry.
[63] K. Jellinger,et al. Normal Mitochondrial Genome in Brain from Patients with Parkinson's Disease and Complex I Defect , 1990, Journal of neurochemistry.
[64] A. H. V. Schapira,et al. MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE , 1989, The Lancet.
[65] L. Luo,et al. A protocol for dissecting Drosophila melanogaster brains for live imaging or immunostaining , 2006, Nature Protocols.
[66] I. Fridovich,et al. The role of O2.- in the production of HO.: in vitro and in vivo. , 1994, Free radical biology & medicine.
[67] D. Brahams. Medicine and the law. Consent to medical treatment in prison. , 1983, Lancet.